Dr. Parker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
250 Chateau Dr SW
Ste 115
Huntsville, AL 35801Phone+1 256-533-4645Fax+1 256-808-3178
Education & Training
University of Alabama Medical CenterFellowship, Infectious Disease, 1991 - 1994
University of FloridaResidency, Internal Medicine, 1988 - 1991
Albany Medical CollegeClass of 1988
Certifications & Licensure
AL State Medical License 1991 - 2024
Clinical Trials
- Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults
- Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive Start of enrollment: 2006 Oct 01
- Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults Start of enrollment: 2007 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 29 citationsEffect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: A randomized trialJennifer G. Wright, Brian D. Plikaytis, Charles E. Rose, Scott D. Parker, Janiine Babcock
Vaccine. 2014-02-12 - 30 citationsThe role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed.Nicholas M. Pajewski, Scott D. Parker, G.A. Poland, Inna G. Ovsyannikova, Wei Song
Genes and Immunity. 2011-09-01 - 76 citationsEffects of a Reduced Dose Schedule and Intramuscular Administration of Anthrax Vaccine Adsorbed on Immunogenicity and Safety at 7 Months: A Randomized TrialNina Marano, Brian D. Plikaytis, Stacey W. Martin, Charles E. Rose, Vera A. Semenova
JAMA. 2008-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
